P. Ferrer

Safety and pharmacokinetics of single doses of aclidinium bromide, a novel long-acting, inhaled antimuscarinic, in healthy subjects.

E. G. Gil, R. Lamarca, E. Garcia Gil, 2009, International journal of clinical pharmacology and therapeutics.

Tolerability and Efficacy of Almotriptan in the Long-Term Treatment of Migraine

J. Pascual, P. Ferrer, R. Falk, 2001, European Neurology.

Consistent Efficacy and Tolerability of Almotriptan in the Acute Treatment of Multiple Migraine Attacks: Results of a Large, Randomized, Double-Blind, Placebo-Controlled Study

J. Zayas, J. Pascual, R. Segarra, 2000, Cephalalgia : an international journal of headache.

Activity of aclidinium bromide, a new long-acting muscarinic antagonist: a phase I study.

R. Pauwels, G. Joos, J. Jansat, 2010, British Journal of Clinical Pharmacology.

Long‐term Efficacy and Safety of Oral Almotriptan: Interim Analysis of a 1‐Year Open Study

P. Ferrer, X. Cabarrocas, Xavier Cabarrocas, 2001, Headache.